Network meta-analysis in metastatic castration-sensitive prostate cancer incl. final ARANOTE data: darolutamide + docetaxel + ADT ranked best vs ADT alone for PFS (HR 0.27) and OS (HR 0.52); darolutamide + ADT ranked best on safety.
Meta-analysis
Shore et al. Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data